Which pharmaceutical product launch involved the innovative 'named patient program' strategy before full approval, allowing limited access to patients with life-threatening conditions?

The medical industry has seen some remarkable product launches that revolutionized healthcare and treatment options. These launches not only represented medical breakthroughs but also showcased innovative product strategies. Test your knowledge about significant pharmaceutical product launches that changed the medical landscape and how they were introduced to the market.

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Imatinib (Gleevec) for chronic myeloid leukemia by Novartis in 2001
Lipitor for cholesterol management by Pfizer in 1996
Humira for rheumatoid arthritis by Abbott in 2002
Prozac for depression by Eli Lilly in 1987